
CASDIN CAPITAL, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | LAB | 88.78M | $113.64M |
![]() | RLAY | 13.00M | $110.01M |
![]() | BLFS | 5.96M | $144.04M |
![]() | PACB | 4.22M | $7.90M |
![]() | PRME | 3.17M | $10.99M |
![]() | WGS | 3.01M | $391.11M |
![]() | RVMD | 2.58M | $205.28M |
![]() | DNLI | 1.84M | $30.38M |
![]() | BEAM | 1.60M | $44.35M |
![]() | SPRY | 1.60M | $18.64M |
![]() | TSHA | 1.50M | $8.25M |
![]() | TXG | 1.40M | $22.83M |
![]() | NGNE | 1.30M | $26.68M |
![]() | IPSC | 1.23M | $1.22M |
![]() | GPCR | 1.18M | $81.72M |
![]() | RNA | 1.00M | $72.13M |
![]() | ABSI | 973K | $3.40M |
![]() | MAZE | 759K | $31.44M |
![]() | ILMN | 600K | $78.70M |
![]() | SEPN | 553K | $15.43M |

Standard BioTools Inc.
LAB
Shares Held
88.78M
Value
$113.64M

Relay Therapeutics, Inc.
RLAY
Shares Held
13.00M
Value
$110.01M

BioLife Solutions, Inc.
BLFS
Shares Held
5.96M
Value
$144.04M

Pacific Biosciences of California, Inc.
PACB
Shares Held
4.22M
Value
$7.90M

Prime Medicine, Inc.
PRME
Shares Held
3.17M
Value
$10.99M

GeneDx Holdings Corp.
WGS
Shares Held
3.01M
Value
$391.11M

Revolution Medicines, Inc.
RVMD
Shares Held
2.58M
Value
$205.28M

Denali Therapeutics Inc.
DNLI
Shares Held
1.84M
Value
$30.38M

Beam Therapeutics Inc.
BEAM
Shares Held
1.60M
Value
$44.35M

ARS Pharmaceuticals, Inc.
SPRY
Shares Held
1.60M
Value
$18.64M

Taysha Gene Therapies, Inc.
TSHA
Shares Held
1.50M
Value
$8.25M

10x Genomics, Inc.
TXG
Shares Held
1.40M
Value
$22.83M

Neurogene Inc.
NGNE
Shares Held
1.30M
Value
$26.68M

Century Therapeutics, Inc.
IPSC
Shares Held
1.23M
Value
$1.22M

Structure Therapeutics Inc.
GPCR
Shares Held
1.18M
Value
$81.72M

Avidity Biosciences, Inc.
RNA
Shares Held
1.00M
Value
$72.13M

Absci Corporation
ABSI
Shares Held
973K
Value
$3.40M

Maze Therapeutics, Inc.
MAZE
Shares Held
759K
Value
$31.44M

Illumina, Inc.
ILMN
Shares Held
600K
Value
$78.70M

Septerna, Inc.
SEPN
Shares Held
553K
Value
$15.43M
